ALAD Antikörper (AA 1-339)
-
- Target Alle ALAD Antikörper anzeigen
- ALAD (Aminolevulinate Dehydratase (ALAD))
-
Bindungsspezifität
- AA 1-339
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser ALAD Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Rabbit polyclonal antibody raised against a full-length human ALAD protein.
- Sequenz
- MPLCPLAHAM QPQSVLHSGY FHPLLRAWQT ATTTLNASNL IYPIFVTDVP DDIQPITSLP GVARYGVKRL EEMLRPLVEE GLRCVLIFGV PSRVPKDERG SAADSEESPA IEAIHLLRKT FPNLLVACDV CLCPYTSHGH CGLLSENGAF RAEESRQRLA EVALAYAKAG CQVVAPSDMM DGRVEAIKEA LMAHGLGNRV SVMSYSAKFA SCFYGPFRDA AKSSPAFGDR RCYQLPPGAR GLALRAVDRD VREGADMLMV KPGMPYLDIV REVKDKHPDL PLAVYHVSGE FAMLWHGAQA GAFDLKAAVL EAMTAFRRAG ADIIITYYTP QLLQWLKEE
- Kreuzreaktivität
- Human
- Produktmerkmale
- Antibody reactive against mammalian transfected lysate.
- Immunogen
- ALAD (NP_000022.2, 1 a.a. ~ 339 a.a) full-length human protein.
- Top Product
- Discover our top product ALAD Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy." in: Cancer research, Vol. 71, Issue 18, pp. 6040-50, (2011) (PubMed).
: "
-
Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy." in: Cancer research, Vol. 71, Issue 18, pp. 6040-50, (2011) (PubMed).
-
- Target
- ALAD (Aminolevulinate Dehydratase (ALAD))
- Andere Bezeichnung
- ALAD (ALAD Produkte)
- Hintergrund
-
Full Gene Name: aminolevulinate, delta-, dehydratase
Synonyms: ALADH,MGC5057,PBGS - Gen-ID
- 210
- NCBI Accession
- NM_000031
-